Literature DB >> 24385511

MicroRNA control of high-density lipoprotein metabolism and function.

Katey J Rayner1, Kathryn J Moore.   

Abstract

Recent discoveries of microRNAs (miRNAs) that control high-density lipoprotein abundance and function have expanded our knowledge of the mechanisms regulating this important lipoprotein subclass. miRNAs have been shown to regulate gene networks that control high-density lipoprotein biogenesis and uptake, as well as discrete steps in the reverse cholesterol transport pathway. Furthermore, high-density lipoprotein itself has been shown to transport miRNAs selectively in health and disease, offering new possibilities of how this lipoprotein may alter gene expression in distal target cells and tissues. Collectively, these discoveries offer new insights into the mechanisms governing high-density lipoprotein metabolism and function and open new avenues for the development of therapeutics for the treatment of cardiovascular disease.

Entities:  

Keywords:  cholesterol, HDL; lipid metabolism; microRNAs

Mesh:

Substances:

Year:  2014        PMID: 24385511      PMCID: PMC4367480          DOI: 10.1161/CIRCRESAHA.114.300645

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  102 in total

1.  Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.

Authors:  Liam R Brunham; Janine K Kruit; Terry D Pape; John S Parks; Folkert Kuipers; Michael R Hayden
Journal:  Circ Res       Date:  2006-08-31       Impact factor: 17.367

2.  Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.

Authors:  Amir Hooshang Mohammadpour; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

3.  Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques.

Authors:  Jonathan E Feig; Sajesh Parathath; James X Rong; Stephanie L Mick; Yuliya Vengrenyuk; Lisa Grauer; Stephen G Young; Edward A Fisher
Journal:  Circulation       Date:  2011-02-21       Impact factor: 29.690

4.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

5.  microRNA-101 is a potent inhibitor of autophagy.

Authors:  Lisa B Frankel; Jiayu Wen; Michael Lees; Maria Høyer-Hansen; Thomas Farkas; Anders Krogh; Marja Jäättelä; Anders H Lund
Journal:  EMBO J       Date:  2011-09-13       Impact factor: 11.598

6.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

7.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

8.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

9.  miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets.

Authors:  Nadeeja Wijesekara; Lin-hua Zhang; Martin H Kang; Thomas Abraham; Alpana Bhattacharjee; Garth L Warnock; C Bruce Verchere; Michael R Hayden
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

10.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Authors:  Katey J Rayner; Christine C Esau; Farah N Hussain; Allison L McDaniel; Stephanie M Marshall; Janine M van Gils; Tathagat D Ray; Frederick J Sheedy; Leigh Goedeke; Xueqing Liu; Oleg G Khatsenko; Vivek Kaimal; Cynthia J Lees; Carlos Fernandez-Hernando; Edward A Fisher; Ryan E Temel; Kathryn J Moore
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

View more
  25 in total

1.  MicroRNA-management of lipoprotein homeostasis.

Authors:  Xinghui Sun; Mark W Feinberg
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

2.  Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.

Authors:  Denuja Karunakaran; A Brianne Thrush; My-Anh Nguyen; Laura Richards; Michele Geoffrion; Ragunath Singaravelu; Eleni Ramphos; Prakriti Shangari; Mireille Ouimet; John P Pezacki; Kathryn J Moore; Ljubica Perisic; Lars Maegdefessel; Ulf Hedin; Mary-Ellen Harper; Katey J Rayner
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

3.  microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.

Authors:  Mireille Ouimet; Hasini Ediriweera; Milessa Silva Afonso; Bhama Ramkhelawon; Ragunath Singaravelu; Xianghai Liao; Rachel C Bandler; Karishma Rahman; Edward A Fisher; Katey J Rayner; John P Pezacki; Ira Tabas; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-20       Impact factor: 8.311

4.  MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis.

Authors:  Mireille Ouimet; Hasini N Ediriweera; U Mahesh Gundra; Frederick J Sheedy; Bhama Ramkhelawon; Susan B Hutchison; Kaitlyn Rinehold; Coen van Solingen; Morgan D Fullerton; Katharine Cecchini; Katey J Rayner; Gregory R Steinberg; Phillip D Zamore; Edward A Fisher; P'ng Loke; Kathryn J Moore
Journal:  J Clin Invest       Date:  2015-10-26       Impact factor: 14.808

Review 5.  HDL-targeted therapies: progress, failures and future.

Authors:  Bronwyn A Kingwell; M John Chapman; Anatol Kontush; Norman E Miller
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

6.  miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome.

Authors:  Rebecca Hutcheson; Jennifer Chaplin; Brenda Hutcheson; Faye Borthwick; Spencer Proctor; Sarah Gebb; Rashmi Jadhav; Erika Smith; James C Russell; Petra Rocic
Journal:  FASEB J       Date:  2014-06-05       Impact factor: 5.191

Review 7.  Long noncoding RNAs in lipid metabolism.

Authors:  Coen van Solingen; Kaitlyn R Scacalossi; Kathryn J Moore
Journal:  Curr Opin Lipidol       Date:  2018-06       Impact factor: 4.776

Review 8.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

9.  Human MicroRNA-33b Promotes Atherosclerosis in Apoe-/- Mice.

Authors:  M Mahmood Hussain; Ira J Goldberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

10.  Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein.

Authors:  Mulugeta Seneshaw; Faridoddin Mirshahi; Hae-Ki Min; Amon Asgharpour; Shervin Mirshahi; Kalyani Daita; Sherry Boyett; Prasanna K Santhekadur; Michael Fuchs; Arun J Sanyal
Journal:  J Vis Exp       Date:  2016-07-27       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.